Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.42
-0.67 (-6.04%)
At close: Sep 23, 2026, 4:00 PM EDT
10.24
-0.18 (-1.77%)
After-hours: Sep 23, 2026, 7:55 PM EDT
Sagimet Biosciences Employees
Sagimet Biosciences had 16 employees as of December 31, 2025. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,942,438
Market Cap
647.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 2 | 14.29% | 16 | 0 |
| Dec 31, 2024 | 14 | 4 | 40.00% | 14 | 0 |
| Dec 31, 2023 | 10 | 0 | - | 8 | 2 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2020 | 7 | - | - | 6 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| DBV Technologies | 170 |
| Neurogene | 131 |
| Aura Biosciences | 113 |
| OmniAb | 89 |
| Crescent Biopharma | 69 |
| Zevra Therapeutics | 61 |
| Oculis Holding AG | 60 |
SGMT News
- 14 days ago - Sagimet Biosciences Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 14 days ago - Cantor starts Sagimet at Overweight on potential in acne - TheFly
- 14 days ago - Sagimet Biosciences initiated with an Overweight at Cantor Fitzgerald - TheFly
- 14 days ago - Sagimet Biosciences upgraded to Overweight from Equal Weight at Barclays - TheFly
- 21 days ago - Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Sagimet Biosciences advances AURORA clinical trial - TheFly
- 4 weeks ago - Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026 - GlobeNewsWire
- 5 weeks ago - Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire